Accès à distance ? S'identifier sur le proxy UCLouvain
NOD2/CARD15 does not influence response to infliximab in Crohn's disease.
Primary tabs
Document type | Article de périodique (Journal article) – Article de recherche |
---|---|
Access type | Accès restreint |
Publication date | 2002 |
Language | Anglais |
Journal information | "Gastroenterology" - Vol. 123, no.1, p. 106-111 (2002) |
Peer reviewed | yes |
issn | 0016-5085 |
Publication status | Publié |
Affiliations |
UCL
- MD/MINT - Département de médecine interne UCL - (SLuc) Service d'hépato-gastro-entérologie |
MESH Subject | Adult ; Antibodies, Monoclonal ; Carrier Proteins ; Cohort Studies ; Crohn Disease ; Female ; Gastrointestinal Agents ; Gene Frequency ; Genotype ; Humans ; Infliximab ; Intracellular Signaling Peptides and Proteins ; Male ; Nod2 Signaling Adaptor Protein ; Predictive Value of Tests ; Reference Values ; Treatment Outcome ; Tumor Necrosis Factor-alpha |
Links |
Bibliographic reference | Vermeire, Severine ; Louis, Edouard ; Rutgeerts, Paul ; De Vos, Martine ; Van Gossum, Andre ; et. al. NOD2/CARD15 does not influence response to infliximab in Crohn's disease.. In: Gastroenterology, Vol. 123, no.1, p. 106-111 (2002) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/232509 |